Small EJ - Search Results

1

Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.

Aggarwal R, Huang J, Alumkal JJ, Zhang L, Feng FY, Thomas GV, Weinstein AS, Friedl V, Zhang C, Witte ON, Lloyd P, Gleave M, Evans CP, Youngren J, Beer TM, Rettig M, Wong CK, True L, Foye A, Playdle D, Ryan CJ, Lara P, Chi KN, Uzunangelov V, Sokolov A, Newton Y, Beltran H, Demichelis F, Rubin MA, Stuart JM, Small EJ. Aggarwal R, et al. Among authors: small ej. J Clin Oncol. 2018 Aug 20;36(24):2492-2503. doi: 10.1200/JCO.2017.77.6880. Epub 2018 Jul 9. J Clin Oncol. 2018. PMID: 29985747 Free PMC article. Clinical Trial.

2

Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy.

Timmerman JM, Northfelt DW, Small EJ. Timmerman JM, et al. Among authors: small ej. J Clin Oncol. 1995 Jun;13(6):1391-7. doi: 10.1200/JCO.1995.13.6.1391. J Clin Oncol. 1995. PMID: 7538557

3

Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer.

Small EJ, Srinivas S, Egan B, McMillan A, Rearden TP. Small EJ, et al. J Clin Oncol. 1996 May;14(5):1617-25. doi: 10.1200/JCO.1996.14.5.1617. J Clin Oncol. 1996. PMID: 8622080 Clinical Trial.

4

Prostate cancer.

Small EJ. Small EJ. Curr Opin Oncol. 1997 May;9(3):277-86. doi: 10.1097/00001622-199709030-00011. Curr Opin Oncol. 1997. PMID: 9229151 Review.

5

Update on the diagnosis and treatment of prostate cancer.

Small EJ. Small EJ. Curr Opin Oncol. 1998 May;10(3):244-52. doi: 10.1097/00001622-199805000-00012. Curr Opin Oncol. 1998. PMID: 9619361 Review.

6

Advances in prostate cancer.

Small EJ. Small EJ. Curr Opin Oncol. 1999 May;11(3):226-35. doi: 10.1097/00001622-199905000-00016. Curr Opin Oncol. 1999. PMID: 10328599 Review.

7

Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone.

Small EJ, Meyer M, Marshall ME, Reyno LM, Meyers FJ, Natale RB, Lenehan PF, Chen L, Slichenmyer WJ, Eisenberger M. Small EJ, et al. J Clin Oncol. 2000 Apr;18(7):1440-50. doi: 10.1200/JCO.2000.18.7.1440. J Clin Oncol. 2000. PMID: 10735891 Clinical Trial.

8

An update on prostate cancer research.

Small EJ, Reese DM. Small EJ, et al. Curr Opin Oncol. 2000 May;12(3):265-72. doi: 10.1097/00001622-200005000-00014. Curr Opin Oncol. 2000. PMID: 10841200 Review.

9

Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point.

Small EJ, Lew D, Redman BG, Petrylak DP, Hammond N, Gross HM, Eastham JA, Crawford ED. Small EJ, et al. J Clin Oncol. 2000 Jul;18(13):2537-44. doi: 10.1200/JCO.2000.18.13.2537. J Clin Oncol. 2000. PMID: 10893284 Clinical Trial.

10

Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.

Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, Kelly WK, Corry M, Reese DM. Small EJ, et al. J Clin Oncol. 2000 Nov 1;18(21):3595-603. doi: 10.1200/JCO.2000.18.21.3595. J Clin Oncol. 2000. PMID: 11054432 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

476 results

Search Page

Filters